AssetMark Inc’s LeMaitre Vascular LMAT Stock Holding History

AssetMark Inc’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.59K	Sell	104 -6	-5%	-$531	﹤0.01%	2568
2026 Q2	$10.6K	Hold	110	–	–	﹤0.01%	2427
2026 Q1	$12K	Buy	110 +7	+7%	+$667	﹤0.01%	2249
2025 Q4	$8.35K	Buy	103 +9	+10%	+$775	﹤0.01%	2282
2025 Q3	$8.23K	Buy	94 +52	+124%	+$4.64K	﹤0.01%	2179
2025 Q2	$3.49K	Buy	+42	New	+$3.51K	﹤0.01%	2248
2018 Q1	–	Sell	-4	Closed	–	–	1721
2017 Q4	$0	Buy	+4	New	+$137	﹤0.01%	2008

Other funds holding LMAT

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

AssetMark Inc's LMAT Position: Q3 2026 in Review

AssetMark Inc reduced its LeMaitre Vascular (LMAT) stake by 5.5% in Q3 2026, selling an estimated $531 and leaving 104 shares worth $8.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

AssetMark Inc first reported a position in LMAT in Q4 2017 and has held it in 7 quarters since. The position peaked at $12K in Q1 2026. 127 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

AssetMark Inc held 104 shares of LeMaitre Vascular worth $8.59K as of Q3 2026.
AssetMark Inc sold 6 LeMaitre Vascular shares in Q3 2026, an estimated $531.
LeMaitre Vascular made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2568 holding.
AssetMark Inc first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 7 quarters since.
AssetMark Inc's LeMaitre Vascular position peaked at $12K in Q1 2026.
127 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.